ubuvuzi butari kanseri y'ibihaha ivura hafi yanjye

Kubona Uburenganzira Umuti Utari muto Uturemangingo twa Kanseri y'ibihaha Kuvura hafi yanjye

Iki gitabo cyuzuye kiragufasha kuyobora ingorane zo kubona neza kuvura kanseri y'ibihaha itari nto (NSCLC) amahitamo hafi yawe. Dushakisha uburyo butandukanye bwo kuvura, gutekereza kubitekerezo byo guhitamo neza, hamwe nibikoresho byo gufasha urugendo rwawe.

Gusobanukirwa Kanseri y'ibihaha itari mito

NSCLC ni iki?

Kanseri y'ibihaha itari ntoya ni ubwoko bwa kanseri y'ibihaha ikunze kugaragara, bingana na 80-85% by'indwara zose za kanseri y'ibihaha. Yashyizwe mubice bitandukanye, buri kimwe gifite imiterere yihariye igira ingaruka kubikorwa byo kuvura. Kumenya hakiri kare ningirakamaro kugirango umusaruro ushimishije. Gusobanukirwa ubwoko bwihariye bwa NSCLC ni intambwe yingenzi muguhitamo inzira nziza ya ubuvuzi butari kanseri y'ibihaha ivura hafi yanjye.

Gutegura no Gusuzuma

Gutegura neza - kumenya urugero rwa kanseri ikwirakwira - ni ngombwa mu gutegura ubuvuzi butari kanseri y'ibihaha ivura hafi yanjye. Ibi birimo ibizamini bitandukanye, birimo amashusho yerekana amashusho (CT, PET), biopsies, hamwe no gupima amaraso. Icyiciro gitegeka uburyo bukwiye bwo kuvura. Kurugero, icyiciro cya mbere NSCLC irashobora kuvurwa no kubagwa wenyine, mugihe ibyiciro byambere bishobora gusaba guhuza imiti.

Amahitamo yo kuvura NSCLC

Kubaga

Kubaga ikibyimba ni uburyo bwambere bwo kuvura NSCLC yo hambere. Uburyo bwihariye buterwa nikibyimba hamwe nubunini. Ibi birashobora kuba birimo lobectomy (kuvanaho ibihaha), pneumonectomy (kuvanaho ibihaha byose), cyangwa kwanga wedge (kuvanaho agace gato k'ibihaha). Nyuma yo kubagwa, gusubiza mu buzima busanzwe ni ngombwa mu gukira.

Chimoterapi

Chimoterapi ikoresha imiti yica kanseri. Bikunze gukoreshwa mbere yo kubagwa (neoadjuvant) kugabanya ikibyimba, nyuma yo kubagwa (adjuvant) kugirango ikureho kanseri zisigaye, cyangwa nkubuvuzi bwibanze bwa NSCLC yateye imbere. Imiti isanzwe ya chimiotherapie kuri NSCLC irimo cisplatine, karboplatine, paclitaxel, na docetaxel. Ingaruka zinyuranye ziratandukanye ariko akenshi zirashobora gucungwa no kwitabwaho.

Ubuvuzi

Imiti ivura imirasire ikoresha imirasire yingufu nyinshi kugirango yangize kandi isenye selile. Irashobora gukoreshwa wenyine, mbere cyangwa nyuma yo kubagwa, cyangwa hamwe na chimiotherapie. Imirasire yo hanze ikoreshwa cyane, itanga imirasire ivuye mumashini hanze yumubiri. Rimwe na rimwe, brachytherapy (imirasire yimbere) irashobora gutekerezwa.

Ubuvuzi bugamije

Imiti igamije kuvura yibanda kuri molekile zihariye ziri mu ngirabuzimafatizo za kanseri, bikabuza gukura no kubaho. Ubu buryo bwo kuvura bugira akamaro cyane cyane ku barwayi ba NSCLC bafite ihinduka ry’imiterere yihariye, nka EGFR, ALK, cyangwa ROS1. Kwipimisha buri gihe kugirango umenye ihinduka ryimiterere ni ngombwa kugirango hamenyekane ibisabwa kugirango bivurwe. Ingero zirimo Osimertinib (Tagrisso), Crizotinib (Xalkori), na Afatinib (Gilotrif).

Immunotherapy

Immunotherapy ikoresha imbaraga z'umubiri zo kurwanya kanseri. Ikora mukuzamura ubushobozi bwumubiri bwo kumenya no gutera kanseri. Imiti ikingira indwara, nka pembrolizumab (Keytruda) na nivolumab (Opdivo), ikora neza ku barwayi bamwe na bamwe ba NSCLC, akenshi ikajyana na chimiotherapie cyangwa ubundi buvuzi. Ingaruka zirashobora kuba zirimo umunaniro, kurwara uruhu, hamwe nibibazo biterwa nubudahangarwa.

Kubona Umuti Ukwiye Hafi yawe

Guhitamo Ikigo Cy'ubuvuzi

Guhitamo ikigo cyujuje ibyangombwa oncology nibyingenzi. Shakisha ibigo bifite inararibonye za oncologiste, tekinoroji igezweho, hamwe nibikorwa bikomeye mubuvuzi bwa NSCLC. Reba ibintu nko kuba hafi y'urugo rwawe, izina ryikigo, hamwe no kuvurwa kabuhariwe, ibizamini byamavuriro, na serivisi zifasha. Reba kuri interineti hanyuma ushakishe ibyifuzo byumuganga wawe wibanze cyangwa inzobere mu buvuzi bwizewe.

Ibigeragezo bya Clinical

Kwitabira igeragezwa rya clinique bitanga uburyo bwo kuvura bigezweho bitaraboneka henshi. Ibi bigeragezo byateguwe neza kugirango bipime imiti mishya no kunoza ibisubizo byubuvuzi. Oncologue wawe arashobora kugufasha kumenya niba igeragezwa ryamavuriro rihuye nibihe byihariye. Urashobora kandi gushakisha ububiko bwamavuriro nka ClinicalTrials.gov kugirango ubone ubushakashatsi bujyanye.

Inkunga n'umutungo

Kuyobora indwara ya kanseri birashobora kugorana. Shakisha inkunga y'amarangamutima kandi ifatika binyuze mumatsinda atera inkunga, amashyirahamwe ya kanseri (urugero: Ishyirahamwe ryabanyamerika ryibihaha, Fondasiyo ya Kanseri yibihaha yo muri Amerika), hamwe na serivisi zubujyanama. Ibikoresho bitanga amakuru yingenzi, ubuyobozi, ninkunga yamarangamutima kubarwayi nimiryango yabo.

Icyitonderwa cyingenzi

Aya makuru ni ayubumenyi rusange kandi ntabwo agizwe ninama zubuvuzi. Ni ngombwa kugisha inama inzobere mu bijyanye na oncologue cyangwa inzobere mu buvuzi kugira ngo isuzume umuntu ku giti cye, igenamigambi ryo kuvura, hamwe n'ubuvuzi buhoraho bujyanye na kuvura kanseri y'ibihaha itari nto. Amakuru yatanzwe hano ntabwo asimbuye inama zubuvuzi zumwuga. Buri gihe shakisha inama kwa muganga wawe cyangwa abandi batanga ubuzima babishoboye bafite ibibazo ushobora kuba ufite bijyanye nuburwayi.

Kubindi bisobanuro cyangwa gushakisha uburyo bwo kuvura mubigo bikomeye byubushakashatsi bwa kanseri, sura Shandong Baofa Ikigo Cyubushakashatsi Kanseri.